Artificial Intelligence Systems as Prognostic and Predictive Tools in Ovarian Cancer

Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC).

(2017) J. A. Ledermann et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection

(2013) F. Collinson et al.   CLINICAL CANCER RESEARCH

Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer

(2011) Ahmed Elattar et al.   GYNECOLOGIC ONCOLOGY

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

(2011) Timothy J. Perren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience

(2010) Tate Thigpen et al.   CANCER

Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors

(2010) A. Mukhopadhyay et al.   CLINICAL CANCER RESEARCH

The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma

(2009) CG Gerestein et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Cancer antigen 125 and prognosis

(2009) Estrid Høgdall   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer

(2008) Ritu Salani et al.   GYNECOLOGIC ONCOLOGY

Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaizen

(2008) Robert E. Bristow   GYNECOLOGIC ONCOLOGY

Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer

(2008) S.J. Wilkinson et al.   HUMAN PATHOLOGY